In a study on the effect of GKN1 polymorphism on the efficacy of cisplatin chemotherapy in lung cancer, it has been found that GKN1 polymorphism significantly reduce the chemotherapy response of lung cancer patients 39. This evidence concerns the gene GKN1 and lung carcinoma.